Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

NEWS

A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression.

PUBLISHED

27 January 2023

RECENT POSTS

Jennifer Stinson Receives the 2025 Peter Gilgan Canada Gairdner Momentum Award

23 April 2025

IASP Hosts Its First African Pain Camp

03 April 2025

Khaliun Gan-Erdene, MD, Awarded the 2025 Siriraj International Fellowship in Clinical Pain Management

21 March 2025

Position Statement: IASP Reaffirms Commitment to Diversity, Equity, and Inclusion

14 March 2025

The purpose of this research was to assess the role of heparanase (HPSE)/syndecan1 (SDC1)/nerve growth factor (NGF) on cancer pain from melanoma.

Posted in
Share this